BEAT Forex-Nachrichten
HeartBeam Submits 510(k) Application To FDA For AIMI Platform Technology To Diagnose Heart Attacks
Digital healthcare company HeartBeam, Inc. (BEAT) announced Tuesday it has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its HeartBeam AIMI Platform Technology for use in diagnosing heart attacks.
RTTNews
|
vor 876 Tagen
